Stratis

First Human Clinical Study to Assess U.S. Department of Defense DNA Vaccine Candidate against Venezuelan Equine Encephalitis Delivered with PharmaJet Precision Delivery Systems.

Retrieved on: 
Thursday, November 16, 2023
Medical Devices, Medical Supplies, Homeland Security, Public Policy, Government, Clinical Trials, Biotechnology, White House, Federal Government, Health, Pharmaceutical, Stratis, ID, Institutional review board, MCDC, VEE, DNA, IRB, Alphavirus, Clinical trial, Mortality, Epidemic, DTRA, FDA, Venezuelan equine encephalitis virus, NHP, USAMRIID, Use, Injection, Unitary state, Infection, Vaccine

The Phase 1 study, sponsored by PharmaJet, aims to identify the optimal dose, vaccination schedule and delivery system most suitable for use in subsequent broader clinical evaluations of the VEE DNA vaccine candidate.

Key Points: 
  • The Phase 1 study, sponsored by PharmaJet, aims to identify the optimal dose, vaccination schedule and delivery system most suitable for use in subsequent broader clinical evaluations of the VEE DNA vaccine candidate.
  • The VEE DNA vaccine candidate is being evaluated as part of a multi-year agreement between PharmaJet and the Joint Science and Technology Office of the U.S. Defense Threat Reduction Agency (DTRA) .
  • The study, in collaboration with USAMRIID, aims to further advance the clinical assessment of the vaccine with the PharmaJet Precision Delivery Systems: Tropis Intradermal (ID) and Stratis Intramuscular (IM).
  • The PharmaJet Precision Delivery Systems are optimized for field use and have also shown immunogenicity levels higher than with needle-syringe.

Paul Johnson Drywall Completes Acquisition of Stratis Construction

Retrieved on: 
Tuesday, November 7, 2023
Other Construction & Property, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Stratis, Acquisition, PJD, 3D printing

Paul Johnson Drywall LLC (PJD) has completed the acquisition of Stratis Construction Inc. (Stratis), one of the leading drywall subcontractors in Arizona.

Key Points: 
  • Paul Johnson Drywall LLC (PJD) has completed the acquisition of Stratis Construction Inc. (Stratis), one of the leading drywall subcontractors in Arizona.
  • The entire Stratis team, including founder Stratis Matheos and General Manager Mike Burkhart, will be joining PJD as the firm continues to build a scaled drywall installation platform with best-in-class capabilities to serve customers in the nation’s leading residential construction markets.

Brooklyn Chop House Dumplings are now Available Nationwide

Retrieved on: 
Tuesday, October 3, 2023
Stratis, Taste, Heart, Music, Partnership, Friends, Mac, Cheese, Collection, Cooking, Love, Labelle, House, Convenience food, Grocery store, BCH, Walmart

NEW YORK, Oct. 3, 2023 /PRNewswire/ -- Brooklyn Chop House & Brooklyn Chop House Grocer, the Black-Owned restaurant group renowned for its innovative fusion of classic Asian cuisine with New York flair team made up of Robert "Don Pooh" Cummins, Dave Thomas, Charles Suitt, and Stratis Morfogen are thrilled to announce the expansion of their famous dumplings in partnership with legendary artist, actress, author and entrepreneur, Patti LaBelle, and Patti LaBelle Foods into over 1,000 Walmart stores exclusively across the United States. Ms. LaBelle brought this deal to Walmart through her company, ZPAC, which focuses on placing minority companies into big box stores. This exciting development marks a significant milestone for the iconic eatery, bringing its delectable dumplings to a broader audience of food enthusiasts. 

Key Points: 
  • Our audience of food enthusiasts across the US can now savor the delectable dumplings from Brooklyn Chop House in their homes!
  • Brooklyn Chop House and BCH Grocer are known for their commitment to quality and flavor and have garnered a loyal following for their bold and inventive culinary creations.
  • Brooklyn Chop House Grocer Partners expressed their enthusiasm for the collaboration: "We're thrilled to partner with the legendary Patti LaBelle to bring the flavors of Brooklyn Chop House and BCH Grocer dumplings to homes across the nation through Walmart stores.
  • For additional information about Brooklyn Chop House Frozen Dumplings, including product availability and locations, go to BCHGrocer .

Paul Johnson Drywall to Acquire Stratis Construction

Retrieved on: 
Tuesday, August 22, 2023
Residential Building & Real Estate, Commercial Building & Real Estate, Building Systems, Stratis, History, PJD, Sales, Phoenix

Paul Johnson Drywall (“PJD”) has entered into a definitive agreement to acquire Stratis Construction (“Stratis”), one of the leading drywall subcontractors in Arizona.

Key Points: 
  • Paul Johnson Drywall (“PJD”) has entered into a definitive agreement to acquire Stratis Construction (“Stratis”), one of the leading drywall subcontractors in Arizona.
  • Stratis will join PJD as PJD continues to build a scaled drywall installation platform with best-in-class capabilities to serve customers in the nation’s leading residential construction markets.
  • Cole Johnson, President of PJD, said, “Stratis has been a leader in the Phoenix market for nearly three decades, and we couldn’t be more excited to add Stratis to our growing platform.
  • We are excited to continue building the first national drywall installer from here.”
    The entire Stratis team, including founder Stratis Matheos and General Manager Mike Burkhart, is expected to remain with PJD through the transaction and indefinitely into the future.

PharmaJet Announces U.S. Government Award Expansion to Clinically Assess a DNA Vaccine Combined with its Systems

Retrieved on: 
Tuesday, April 18, 2023
Biotechnology, Medical Devices, Infectious Diseases, Health, Pharmaceutical, Stratis, Injection, United States Army Medical Research Institute of Infectious Diseases, DNA, Human, Partnership, Use, Alphavirus, U.S. Department of Defense Strategy for Operating in Cyberspace, USAMRIID, Licensure, Venezuelan equine encephalitis virus, DTRA, ID, Epidemic, Investigational New Drug, PDS, CGMP, Mortality, NHP, Defense Threat Reduction Agency, Encephalitis, IND, Infection, Pharmaceutical industry, Vaccine

The expansion award, worth over $4 million, will be used to further advance the clinical assessment of its Venezuelan Equine Encephalitis Virus (VEEV) DNA candidate vaccine in combination with either Tropis Intradermal (ID) or Stratis Intramuscular (IM) Systems.

Key Points: 
  • The expansion award, worth over $4 million, will be used to further advance the clinical assessment of its Venezuelan Equine Encephalitis Virus (VEEV) DNA candidate vaccine in combination with either Tropis Intradermal (ID) or Stratis Intramuscular (IM) Systems.
  • Venezuelan Equine Encephalitis Virus is an alphavirus that causes encephalitis and potential mortality in infected humans and equines.
  • It is listed as a potential biothreat agent with no approved human vaccine or therapeutic currently available.
  • PharmaJet is working with a contract manufacturer to produce the cGMP VEEV plasmid DNA vaccine and is preparing the Investigational New Drug (IND) application.

Review Highlights Growing Evidence That PharmaJet’s Precision Delivery Devices Improve Nucleic Acid Vaccine Performance

Retrieved on: 
Thursday, February 23, 2023
Biotechnology, Pharmaceutical, Health, Medical Devices, Stratis, Tissue, Safety, HIV, Orthohantavirus, University of Cape Town, Vaccine (journal), DNA, University, Antigen, Bureau of Oceans and International Environmental and Scientific Affairs, Molecular medicine, Injection, Infection, Cell, Use, MDPI, Trial of the century, Subcutaneous tissue, TROPI, Therapy, Probability, Human, Drugs Controller General of India, Multimedia, Messenger, Vaccine, COVID-19, RNA

(Graphic: Business Wire)

Key Points: 
  • (Graphic: Business Wire)
    The COVID-19 pandemic increased visibility of nucleic acid vaccines, such as messenger RNA (mRNA), that provide scalability and can be quickly adapted as new variants appear.
  • Historical limitations can be addressed with new administration technologies such as modern needle-free precision delivery systems.
  • “We currently have eighty-three studies ongoing with novel pharmaceuticals focusing on nucleic acid technology in addition to other new vaccine technology platforms.
  • We believe that our precision delivery devices have the potential to increase the performance and therefore probability of regulatory success of many of these candidate vaccines.”
    Refer to Instructions for Use to ensure safe injections and to review risks.

PharmaJet Partner Immunomic Therapeutics Receives FDA Fast Track Designation for pDNA Vaccine for Skin Cancer

Retrieved on: 
Tuesday, December 13, 2022
Oncology, Medical Supplies, Medical Devices, Health, Pharmaceutical, Biotechnology, Stratis, Therapy, MCC, PQS, Merkel-cell carcinoma, HPV, Certification, Infection, U.S. FDA, Public health, Patient, Communication, DNA, Research, Injection, ITI, System, FDA, Cancer, Lymphoma, Vaccine, Trial of the century, WHO, Use, Skin cancer, CE marking, UNITE, FTD, Allergy, Pharmaceutical industry

We are committed to unlocking the full potential of ITI-3000 in patients with this aggressive form of skin cancer.

Key Points: 
  • We are committed to unlocking the full potential of ITI-3000 in patients with this aggressive form of skin cancer.
  • The PharmaJet Stratis NFIS was chosen due to its ability to precisely deliver the vaccine to the intramuscular tissue layer.
  • We are pleased that our partner Immunomic Therapeutics has received fast track designation for this important DNA therapeutic for aggressive skin cancer, said Chris Cappello, President and CEO, PharmaJet.
  • Clinical programs with Fast Track Designation benefit from early and frequent communication with the FDA throughout the regulatory review process.

Riverside Research Welcomes Chief Human Resources Officer Madelyne D'Angelo

Retrieved on: 
Monday, November 28, 2022
Stratis, Business, Physics, New York City Human Resources Administration, Slippery Rock University of Pennsylvania, Open Architecture Network, Duquesne University, Nondestructive testing, Multimedia, Intelligence, Intelligence community, Government, Activity, Operation, Innovation Center station, Computational electromagnetics, Research, SOSI, Accelerated Christian Education, National security, Dragon Age: Inquisition, Object, Plasma, Commercial, Intelligence collection plan, Equity, United States Department of Defense, Human resources, OIC, CHRO, Plasma (physics), DEI, Management, Science

WASHINGTON, Nov. 28, 2022 /PRNewswire/ -- Riverside Research welcomes Madelyne D'Angelo as the company's Chief Human Resources Officer (CHRO).

Key Points: 
  • WASHINGTON, Nov. 28, 2022 /PRNewswire/ -- Riverside Research welcomes Madelyne D'Angelo as the company's Chief Human Resources Officer (CHRO).
  • D'Angelo brings a combination of significant human resources and operations experience.
  • Invested in enmeshing best HR practices in company growth, D'Angelo's past roles include CHRO at SOS International LLC (SOSi), Vice President of Operations at InquisIT, Vice President, Human Resources at CRGT, and Vice President, Human Resources Administration at L-3 Stratis.
  • "Madelyne brings a unique background and proven skillset to the CHRO role at Riverside.

Goli® Nutrition Announces Bruce Weiss as New Chief Executive Officer

Retrieved on: 
Thursday, September 8, 2022
Stratis, Well, CVS, Church & Dwight, CEO, Coca-Cola, Church, Kroger, Health, Multimedia, Critter, Kraft Foods, Goli, Target, Walmart, IRI, Taste, Amazon, Growth, Management, Online shopping, Walgreens, Costco

WEST HOLLYWOOD, Calif., Sept. 8, 2022 /PRNewswire/ -- Goli® Nutrition Inc. ("Goli®"), the pioneering wellness company recognized as America's #1 Apple Cider Vinegar Brand and #1 Ashwagandha Vitamin Brand¹, announces the appointment of Bruce Weiss as their new Chief Executive Officer. 

Key Points: 
  • WEST HOLLYWOOD, Calif., Sept. 8, 2022 /PRNewswire/ -- Goli Nutrition Inc. ("Goli"), the pioneering wellness company recognized as America's #1 Apple Cider Vinegar Brand and #1 Ashwagandha Vitamin Brand, announces the appointment of Bruce Weiss as their new Chief Executive Officer.
  • Uniquely qualified to evolve the Goli business, Weiss is joined by an impressive, recently appointed, executive-level support team, including Stratis Philippis as Chief Legal Officer, and Elizabeth Carter as Chief Financial Officer.
  • "In 2022, Goli Nutrition experienced significant growth in product innovation that would not have been possible without the right leadership team," shared Goli Co-Founder, Michael Bitensky.
  • "I am honored to join Goli as CEO," said Bruce Weiss, Chief Executive Officer of Goli Nutrition.

PharmaJet Presents Latest Research Showing Benefits of Needle-free at mRNA-Based Therapeutics Summit

Retrieved on: 
Tuesday, July 19, 2022
Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Medical Devices, Infectious Diseases, Stratis, N/S, Research, Public health, LNP, University, Rabies, USAMRIID, Method, LinkedIn, RNA transfection, WHO, Infection, Injection, Safety, DVM, Therapy, Review, System, Lancet, Rabbit, United States Army Medical Research Institute of Infectious Diseases, Certification, Use, Sue VandeWoude, Smallpox, Vaccination, Nucleic acid, COVID-19, ID, PQS, CE marking, Veni, vidi, vici, Doctor of Philosophy, IM, U.S. FDA, Vaccine, TROPI

PharmaJet , a company who has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced that they will present their latest research results at the mRNA-Based Therapeutics Summit on July 27, 2022.

Key Points: 
  • PharmaJet , a company who has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced that they will present their latest research results at the mRNA-Based Therapeutics Summit on July 27, 2022.
  • The presentation, entitled Advances in mRNA vaccines and therapeutics delivery with PharmaJet Needle-free Injection Systems, will be presented by Carmen Ledesma-Feliciano, DVM, PhD, DACLAM, Clinical Device Specialist at PharmaJet.
  • PharmaJet Needle-free Injection Systems (NFIS) are increasingly being incorporated into preclinical and clinical studies across multiple nucleic acid vaccine and therapeutic development programs.
  • This presentationwill highlight several partner studies that show the benefits of the PharmaJet NFIS including improved immunogenicity, dose-reduction, lower cost, and better patient and healthcare worker experience.